Memory Support System Feasibility Study

Launched by BRUYÈRE HEALTH RESEARCH INSTITUTE. · Aug 10, 2023

Keywords

ClinConnect Summary

The Memory Support System Feasibility Study is looking into how well the Memory Support System (MSS) can help individuals with mild cognitive impairment (MCI) and their caregivers. This study, taking place in Ontario, Canada, aims to find out if patients are interested in using the MSS and what the best way to provide it to them might be. Researchers will also analyze the costs of implementing the MSS and collect information on how well participants follow the program, along with its effects on daily living activities, mood, anxiety, and overall quality of life.

To be eligible for this study, participants should have a diagnosis of mild cognitive impairment, be able to interact with a caregiver at least twice a week, and meet certain cognitive test scores. However, those with significant vision or hearing problems, or who are already participating in another study, cannot join. If you or a loved one is interested in participating, you can expect to help researchers understand the MSS and its impact on memory support. This could lead to better care for those with MCI in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of single or multi-domain MCI
• • Clinical Dementia Rating global (CDR) score of ≤ 0.5
• • Montreal Cognitive Assessment score of ≥18
• • available contact with a care partner ≥ 2 times weekly
• • absence or stable intake of nootropic(s) for ≥ 3 months
• Exclusion Criteria:
• • visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training
• • concurrent participation in another related clinical trial